Vaccines and preterm neonates: Why, when, and with what

Susanna Esposito, Domenico Serra, Laura Gualtieri, Laura Cesati, Nicola Principi

Research output: Contribution to journalArticlepeer-review


This review analyses what is known concerning the immune response of preterm (PTIs) and low birth weight infants (LBWIs) to widely used vaccines, the protection they receive from routine immunisation, and the safety and tolerability of the vaccines themselves. It shows why PTIs and LBWIs should be vaccinated using the same schedules as those usually recommended for full-term infants (FTIs), except in the case of hepatitis B vaccine, whose schedule should be repeated in infants who received the first dose during the first days of life when they weighed less than 2000g because of their reduced immune response. Vaccines are immunogenic, safe and well tolerated in PTIs and LBWIs, in whom early active immunisation is particularly important because they are among the most vulnerable subjects for pediatric infectious diseases. It is therefore essential to make every effort to convince pediatricians and parents that compliance with these recommendations will not cause any clinical problems.

Original languageEnglish
JournalEarly Human Development
Issue number10 SUPPL.
Publication statusPublished - Oct 2009


  • Immunisation
  • Neonate
  • Preterm
  • Vaccines

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynaecology


Dive into the research topics of 'Vaccines and preterm neonates: Why, when, and with what'. Together they form a unique fingerprint.

Cite this